Metropolis Healthcare’s wholly owned subsidiary -- Metropolis Clinical Pathology is all set to acquire Agra-based Scientific Pathology through a Business Transfer Agreement (BTA). This strategic move strengthens Metropolis’ presence in Western Uttar Pradesh, accelerates its B2C expansion, and unlocks growth opportunities across the state and beyond.
Under the agreement, Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction. The consideration for the acquisition will range between Rs 55 crore and Rs 83 crore, determined at 12.2x of the adjusted EBITDA over a defined assessment period. The transaction will be executed through a Securities Subscription Cum Shareholders’ Agreement (SHA), backed by Metropolis Healthcare. Upon completion, Metropolis Clinical Pathology will transition from a wholly owned subsidiary while continuing to be an integral part of the Metropolis Healthcare Group.
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 6951.85 |
Max Healthcare Inst | 1068.00 |
Narayana Hrudayalay | 1787.40 |
Aster DM Healthcare | 505.25 |
Global Health | 1214.75 |
View more.. |